Michael Walsh

Has grant

Associate Professor

McMaster University

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Michael Walsh is an Associate Professor at McMaster University in Canada. His research primarily focuses on chronic kidney disease, the impacts of bariatric surgery, and the efficacy of various treatments for kidney failure, including mineralocorticoid receptor antagonists and plasma exchange. He has contributed to several recent studies, including the ACHIEVE and MyTEMP trials, which investigate innovative therapeutic approaches in renal care.

Recent Grants

Grant: Close

Strategies for the management of Atrial Fibrillation in patiEnts receiving HemoDialysis (SAFE-HD)

Open Date: 2018-10-01

Close Date: 2020-09-30

Grant: Close

An Integrated Platform for Innovative Pragmatic Cluster-Randomized Registry Trials in Hemodialysis

Open Date: 2017-01-01

Close Date: 2020-12-31

Grant: Close

Evaluation of the efficacy and safety of health service dialysate sodium practice on clinical outcomes

Open Date: 2017-01-01

Close Date: 2021-01-01

Grant: Close

Evaluation of the efficacy and safety of health service dialysate sodium practice on clinical outcomes

Open Date: 2017-01-01

Close Date: 2021-01-01

Grant: Close

Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease-1 (MPAC-CKD-1)

Open Date: 2016-07-01

Close Date: 2020-09-30

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Collaborators (14)

Kathleen Nicholls

University of Melbourne

AUSTRALIA

View details

Yongdong Ouyang

Assistant Professor

Roswell Park Comprehensive Cancer Center

UNITED STATES

View details

Andreas Kronbichler

Medical University of Innsbruck

AUSTRIA

View details

Miriam de Nadal

Associate Professor

University of Barcelona

SPAIN

View details

Rachel Jones

University of Cambridge

UNITED KINGDOM

View details

Ngan N. Lam

University of Calgary

CANADA

View details

Sophie Ohlsson

Lund University

SWEDEN

View details

Nader Khalidi

McMaster University

CANADA

View details

Kate Leslie

Honorary Professorial Fellow

University of Melbourne

AUSTRALIA

View details

Jesper Nørgaard Bech

Aarhus University

DENMARK

View details

Stephanie Dixon

CANADA

View details

Gary Hoffman

Former Chairman, Professor

Cleveland Clinic

UNITED STATES

View details

Raphaele Seror

Université Paris-Saclay

FRANCE

View details

Peter Merkel

Professor

University of Pennsylvania

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael Walsh

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

Bayesian Analysis of Time-To-Event Data in a Cluster-Randomized Trial: Major Outcomes With Personalized Dialysate TEMPerature (MyTEMP) Trial

Impact of bariatric surgery on patients with chronic kidney disease and severe obesity: multiple-linked population-based cohort study

Safety and efficacy of steroidal mineralocorticoid receptor antagonists in patients with kidney failure requiring dialysis: a systematic review and meta-analysis of randomised controlled trials

Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial

The authors reply

The Aldosterone Blockade for Health Improvement Evaluation in End-Stage Renal Disease (ACHIEVE) Trial: Rationale and Clinical Research Protocol

Does plasma exchange have a role in ANCA-associated vasculitis? Viewpoint 1: plasma exchange should not be used indiscriminately

Preoperative estimated glomerular filtration rate to predict cardiac events in major noncardiac surgery: a secondary analysis of two large international studies

Risk of Relapse of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in a Randomized Controlled Trial of Plasma Exchange and Glucocorticoids

Authors' Reply: Proton Pump Inhibitors May Cause a Decline in eGFR by Inhibiting Organic Cation Transporter 2–Dependent Creatinine Secretion

A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis

The Effects of Pantoprazole on Kidney Outcomes

Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS)

How the Routine Use of Patient-Reported Outcome Measures for Hemodialysis Care Influences Patient-Clinician Communication

Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT

Impact of Bioelectrical Impedance–Guided Fluid Management and Vitamin D Supplementation on Left Ventricular Mass in Patients Receiving Peritoneal Dialysis: A Randomized Controlled Trial

Phase 2 Study of the Factor XI Antisense Inhibitor IONIS-FXIRx in Patients With ESRD

The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysis

Response to: ‘Mycophenolate mofetil: a step forward in the induction treatment of ANCA-associated vasculitis? Comment on the article by Joneset al’by Vandergheynstet al

Implementing a Patient-Reported Outcome Measure for Hemodialysis Patients in Routine Clinical Care

Collaborators (14)

Kathleen Nicholls

Yongdong Ouyang

Andreas Kronbichler

Miriam de Nadal

Rachel Jones

Ngan N. Lam

Sophie Ohlsson

Nader Khalidi

Kate Leslie

Jesper Nørgaard Bech

Stephanie Dixon

Gary Hoffman

Raphaele Seror

Peter Merkel

Make your next move.